{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:25:59Z","timestamp":1791473159954,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22274011"],"award-info":[{"award-number":["22274011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["B2024105013"],"award-info":[{"award-number":["B2024105013"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation Proposed Program","award":["L242138"],"award-info":[{"award-number":["L242138"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03208-1","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:11:48Z","timestamp":1740640308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A self-adjuvant multiantigenic nanovaccines simultaneously activate the antiviral and antitumor immunity for the treatment of cancers"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhongjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuantian","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"3208_CR1","doi-asserted-by":"crossref","unstructured":"Fan T, Zhang MN, Yang JX, Zhu ZA, Cao WL, Dong CY. Therapeutic cancer vaccines: advancements, challenges, and prospects. Signal Transduct Target Therapy. 2023;8.","DOI":"10.1038\/s41392-023-01674-3"},{"key":"3208_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","volume":"24","author":"PD Katsikis","year":"2024","unstructured":"Katsikis PD, Ishii KJ, Schliehe C. Challenges in developing personalized neoantigen cancer vaccines. Nat Rev Immunol. 2024;24:213\u201327.","journal-title":"Nat Rev Immunol"},{"key":"3208_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ymthe.2006.02.009","volume":"13","author":"K Evel-Kabler","year":"2006","unstructured":"Evel-Kabler K, Chen SY. Dendritic cell-based tumor vaccines and antigen presentation attenuators. Mol Ther. 2006;13:850\u20138.","journal-title":"Mol Ther"},{"key":"3208_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jconrel.2022.05.062","volume":"349","author":"CP Liu","year":"2022","unstructured":"Liu CP, Wang YC, Li LM, He DY, Chi JX, Li Q, Wu YX, Zhao YX, Zhang SH, Wang L, et al. Engineered extracellular vesicles and their mimetics for cancer immunotherapy. J Controlled Release. 2022;349:679\u201398.","journal-title":"J Controlled Release"},{"key":"3208_CR5","doi-asserted-by":"crossref","unstructured":"Meng FQ, Lin ZD, Ma YM, Che RB, Zhang C, Wei YT, Song X, Liang X, Zhang XD. Engineered algae microrobots as photosynthetic living materials promote T cells\u2019 anti-tumor immunity. Cell Rep Phys Sci. 2024;5.","DOI":"10.1016\/j.xcrp.2024.102023"},{"key":"3208_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20517\/evcna.2023.58","volume":"5","author":"X Li","year":"2024","unstructured":"Li X, Wei Y, Zhang Z, Zhang X. Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics. Extracell Vesicles Circulating Nucleic Acids. 2024;5:44\u201363.","journal-title":"Extracell Vesicles Circulating Nucleic Acids"},{"key":"3208_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cac2.12518","volume":"44","author":"MK Chen","year":"2024","unstructured":"Chen MK, Chen ZX, Cai MP, Chen H, Chen ZF, Zhao SC. Engineered extracellular vesicles: a new approach for targeted therapy of tumors and overcoming drug resistance. Cancer Commun. 2024;44:205\u201325.","journal-title":"Cancer Commun"},{"key":"3208_CR8","doi-asserted-by":"crossref","unstructured":"Wang ZG, Mo HK, He ZY, Chen AM, Cheng P. Extracellular vesicles as an emerging drug delivery system for cancer treatment: current strategies and recent advances. Biomed Pharmacother. 2022;153.","DOI":"10.1016\/j.biopha.2022.113480"},{"key":"3208_CR9","doi-asserted-by":"crossref","unstructured":"Yue M, Hu SY, Sun HF, Tuo B, Jia B, Chen C, Wang WK, Liu JB, Liu Y, Sun ZQ, Hu JH. Extracellular vesicles remodel tumor environment for cancer immunotherapy. Mol Cancer. 2023;22.","DOI":"10.1186\/s12943-023-01898-5"},{"key":"3208_CR10","first-page":"779","volume":"17","author":"SL Jin","year":"2022","unstructured":"Jin SL, Lv ZY, Kang L, Wang JY, Tan CC, Shen LM, Wang L, Liu J. Next generation of neurological therapeutics: native and bioengineered extracellular vesicles derived from stem cells. Asian J Pharm Sci. 2022;17:779\u201397.","journal-title":"Asian J Pharm Sci"},{"key":"3208_CR11","doi-asserted-by":"crossref","unstructured":"Jiang Q, Wang L, Tian JL, Zhang WJ, Cui HJ, Gui HL, Zang ZH, Li B, Si X. Food-derived extracellular vesicles: natural nanocarriers for active phytoconstituents in new functional food. Crit Rev Food Sci Nutr. 2023.","DOI":"10.1080\/10408398.2023.2242947"},{"key":"3208_CR12","doi-asserted-by":"crossref","unstructured":"Roerig J, Schulz-Siegmund M. Standardization approaches for extracellular vesicle loading with oligonucleotides and biologics. Small. 2023;19.","DOI":"10.1002\/smll.202301763"},{"key":"3208_CR13","doi-asserted-by":"crossref","unstructured":"Ghonime MG, Saini U, Kelly MC, Roth JC, Wang PY, Chen CY, Miller K, Hernandez-Aguirre I, Kim Y, Mo XK et al. Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy. J Immunother Cancer. 2021;9.","DOI":"10.1136\/jitc-2021-002939"},{"key":"3208_CR14","doi-asserted-by":"crossref","unstructured":"Liu GN, Zhu MT, Zhao X, Nie GJ. Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity. Adv Drug Deliv Rev. 2021;176.","DOI":"10.1016\/j.addr.2021.113889"},{"key":"3208_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","volume":"10","author":"BD Lichty","year":"2004","unstructured":"Lichty BD, Power AT, Stojdl DF, Bell JC. Vesicular stomatitis virus: re-inventing the bullet. Trends Mol Med. 2004;10:210\u20136.","journal-title":"Trends Mol Med"},{"key":"3208_CR16","doi-asserted-by":"crossref","unstructured":"Zhang YG, Nagalo BM. Immunovirotherapy based on recombinant vesicular stomatitis virus: where are we? Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.898631"},{"key":"3208_CR17","doi-asserted-by":"crossref","unstructured":"Halajian EA, LeBlanc EV, Gee K, Colpitts CC. Activation of TLR4 by viral glycoproteins: a double-edged sword? Front Microbiol. 2022;13.","DOI":"10.3389\/fmicb.2022.1007081"},{"key":"3208_CR18","doi-asserted-by":"crossref","unstructured":"Gebremeskel S, Nelson A, Walker B, Oliphant T, Lobert L, Mahoney D, Johnston B. Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis. J Immunother Cancer. 2021;9.","DOI":"10.1136\/jitc-2020-002096"},{"key":"3208_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41586-022-04895-8","volume":"607","author":"S Ghosh","year":"2022","unstructured":"Ghosh S, Kumar M, Santiana M, Mishra A, Zhang M, Labayo H, Chibly AM, Nakamura H, Tanaka T, Henderson W, et al. Enteric viruses replicate in salivary glands and infect through saliva. Nature. 2022;607:345.","journal-title":"Nature"},{"key":"3208_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1128\/JVI.01106-12","volume":"87","author":"AN van den Pol","year":"2013","unstructured":"van den Pol AN, Davis JN. Highly attenuated recombinant vesicular stomatitis virus VSV-12\u2032GFP displays immunogenic and oncolytic activity. J Virol. 2013;87:1019\u201334.","journal-title":"J Virol"},{"key":"3208_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.immuni.2009.02.009","volume":"30","author":"S Shelly","year":"2009","unstructured":"Shelly S, Lukinova N, Bambina S, Berman A, Cherry S. Autophagy is an essential component of Drosophila immunity against vesicular stomatitis virus. Immunity. 2009;30:588\u201398.","journal-title":"Immunity"},{"key":"3208_CR22","doi-asserted-by":"crossref","unstructured":"Huang LL, Wang WW, Wang ZJ, Zhang H, Liu HL, Wu GH, Nie WD, Xie HY. Engineering Oncolytic adenoviruses with VSVG-Decorated tumor cell membranes for synergistically enhanced Antitumor Therapy. Adv Funct Mater. 2023;33.","DOI":"10.1002\/adfm.202209056"},{"key":"3208_CR23","doi-asserted-by":"crossref","unstructured":"Wedge ME, Jennings VA, Crupi MJF, Poutou J, Jamieson T, Pelin A, Pugliese G, de Souza CT, Petryk J, Laight BJ et al. Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy. Nat Commun. 2022;13.","DOI":"10.1038\/s41467-022-29526-8"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03208-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:11:59Z","timestamp":1740640319000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03208-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3208"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03208-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Experimental Animal Committee of the Beijing Institute of Technology with an approval number: 2019-0010-M-2023152.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}